Metabolic Endotoxemia and Inhibition of Direct Bone Regeneration: A Pilot Study
E. C. Wahl, J. Aronson, L. Liu, R. A. Skinner, M. J. J. Ronis, C. K. Lumpkin Jr.
Journal of Advances in Medicine and Medical Research · pp. 510–519 · Published 23 Aug 2012
10.9734/BJMMR/2012/1547Abstract
Aims: Clinical and pre-clinical studies have demonstrated that alcohol abuse, aging, diabetes and rheumatoid arthritis are associated with increased risk of fractures compounded with impaired fracture repair. We note that these and other pathologies are characterized by chronic inflammation (CI) as a risk factor. How these CI pathologies inhibit bone repair is unclear, but one candidate mediator is endotoxin (lipopolysaccharide/LPS). LPS promotes inflammation and is present in increased serum concentrations in some inflammatory conditions. The distraction osteogenesis (DO) model developed in this laboratory provides the opportunity to isolate and study the effects of CI on direct bone formation during bone regeneration. The aim of this study was to determine whether endotoxin at concentrations that mimic levels reported in chronic inflammatory conditions would impair bone formation in a mouse model of DO. Study Design: Mouse bone repair study. Place and Duration of Study: Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, April to June 2009. Methodology: LPS or vehicle (PBS) was chronically administered to 11-week old mice via alzet pump. Mice underwent the DO protocol concurrently with LPS administration. Radiographic and histologic quantitation was performed on the DO gap to determine the amount of new bone formed. Results: Radiographic (51.9 ± 7% vehicle vs 21.0 ± 7.3% LPS: P < .01) and histologic (68.1 ± 8.5% vehicle vs 33.6 ±10.3% LPS; P < .02) results indicate that bone formation during DO was significantly decreased in LPS treated versus vehicle treated mice. Conclusion: The magnitude of the osteoinhibitory effects of systemic LPS in this mouse model of CI was equivalent to two months of ethanol treatment, 24 months of aging, or two months of Type 1 diabetes. These results support the hypothesis that LPS exposure could be responsible for the decreased bone formation observed in chronic inflammatory conditions.
Cited by 1
Yixuan Chen, Hongping Yu, Daoyu Zhu · The FASEB Journal · 2020
Related research
- Protection against Helicobacter pylori Infection in BALB/c Mice by Oral or Intramuscular Administration of Multicomponent Vaccine of rCagA +LPS +CpG — shares topic coverage
- Lipopolysaccharide, Mediator of Sepsis Enigma: Recognition and Signaling — shares topic coverage
- Haematological and Histological Effects of Nanoplastics Released from Nonfood-grade Nonwoven Polyethene Bags on Mice — shares topic coverage
- Saba senegalensis (A.DC) Pichon (Apocynaceae): Treatment of Loperamide-induced Constipation in Mice — shares topic coverage
- Evaluation of the Neurobehavioural Toxicity Potential of Aqueous Ethanol Extracts of Leaf/Seed of Datura metel, Mucuna pruriens, and Tapinanthus globiferus Growing on Azadirachta indica Host Tree in Mice — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.